{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.2:c.6059T>C",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "T",
            "alt": "C",
            "position": "6059"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "c.6059T>C (p.I2020T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005072"
  },
  "Experiment Method": [
    {
      "Assay Method": "Transfection of LRRK2 cDNA followed by Western blotting and apoptosis assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293, SH-SY5Y",
        "Description": "The experiment was conducted using the HEK293 and SH-SY5Y cell lines."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.6059T>C",
          "Conclusion": "Impaired protectivity against apoptosis",
          "Molecular Effect": "Increased susceptibility to degradation",
          "Result Description": "I2020T mutant LRRK2 showed impaired protectivity against hydrogen peroxide-induced apoptosis compared to wild-type LRRK2. Prevention of intracellular degradation of I2020T mutant LRRK2 restored its protective effect against apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed with multiple cell lines and clones."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lower percentage of apoptotic cells in WT LRRK2-transfected cells compared to untransfected cells.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Higher percentage of apoptotic cells in I2020T LRRK2-transfected cells compared to WT LRRK2-transfected cells.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}